You are here

  • Home
  • Archive
  • Volume 11, Issue Suppl 1
  • 254 TGF-beta blockade combined with activation-induced IL12 secretion synergize to optimize potency of MUC1-CAR T-cells in preclinical targeting of triple-negative breast cancer

Citation Tools

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Cellular Therapies
254 TGF-beta blockade combined with activation-induced IL12 secretion synergize to optimize potency of MUC1-CAR T-cells in preclinical targeting of triple-negative breast cancer

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Erler P, Cho H, Skinner J, et al
254 TGF-beta blockade combined with activation-induced IL12 secretion synergize to optimize potency of MUC1-CAR T-cells in preclinical targeting of triple-negative breast cancer
Journal for ImmunoTherapy of Cancer 2023;11:doi: 10.1136/jitc-2023-SITC2023.0254